Literature DB >> 18034403

[Solar retinopathy: follow-up examinations with optical coherence tomography (OCT) and microperimetry].

S O Koinzer1, F Treumer, H Elsner, J Roider.   

Abstract

BACKGROUND: Solar retinopathy is a phototoxic damage to the central retina. It may cause visual deterioration and a central scotoma with reading difficulties, that usually fade with time. Morphological and functional changes can be very subtle and are often inadequately detected by standard examinations. PATIENTS AND METHODS: The more affected, left eye of a 41-year-old female patient was examined clinically, by optical coherence tomography (OCT 3) and by MP 1-microperimetry during a 6-month follow up after gazing at a partial eclipse.
RESULTS: At all times visual acuity was reduced to 0.7 causing visual deterioration. OCT examinations showed a subfoveal damage of decreasing extent, which was still detectable after 6 months. The retinal affection resulted in a persistent microscotoma of decreasing depth.
CONCLUSION: OCT 3 and MP 1-microperimetry are able to detect the morphological and the functional damages in solar retinopathy at a level of sensitivity good enough to produce correlating results which allow the detection of subtle changes during follow-up.

Entities:  

Mesh:

Year:  2007        PMID: 18034403     DOI: 10.1055/s-2007-963685

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  3 in total

Review 1.  [Light exposition in vitreoretinal surgery. I. Basics].

Authors:  A E Höh; T Ach; R Amberger; S Dithmar
Journal:  Ophthalmologe       Date:  2008-10       Impact factor: 1.059

2.  [Eclipse retinopathy : A case series after the partial solar eclipse on 20 March 2015].

Authors:  I Bachmeier; H Helbig; R Greslechner
Journal:  Ophthalmologe       Date:  2017-01       Impact factor: 1.059

3.  [Sudden bilateral loss of vision with scotomas].

Authors:  Alexander C Rokohl; Gerhard Welsandt; Ludwig M Heindl; Friederike Schaub; Sigrid Roters
Journal:  Ophthalmologe       Date:  2021-04-29       Impact factor: 1.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.